Mayo Clinic laboratory and pathology research roundup: December 14

The research roundup provides an overview of the past week’s research from Mayo Clinic Laboratories consultants, including featured abstracts and a complete list of published studies and reviews.

Featured Abstract

Lewy body disease is a contributor to logopenic progressive aphasia phenotype.

To describe clinical features, [18 F]-fluorodeoxyglucose (FDG)-PET metabolism and digital pathology in patients with logopenic progressive aphasia and pathologic diagnosis of diffuse Lewy body disease (LPA-DLBD) and compare to LPA patients with other pathologies, as well as patients with classical features of probable dementia with Lewy bodies (pDLB). Via Annals in Neurology

Read more.

Published to PubMed This Week

Samantha Rossi

Samantha Rossi is a Digital Marketing Manager at Mayo Clinic Laboratories. She supports marketing strategies for product management and specialty testing. Samantha has worked at Mayo Clinic since 2019.